Vanguard Group
VVOS icon

Vanguard Group’s Vivos Therapeutics VVOS Stock Holding History

Vanguard Group’s Portfolio VVOS Stock Details VVOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$617K Buy
304,161
+212,700
+233% +$527K ﹤0.01% 3898
2025
Q3 		$284K Buy
91,461
+48,827
+115% +$221K ﹤0.01% 4065
2025
Q2 		$135K Hold
42,634
– – ﹤0.01% 4120
2025
Q1 		$122K Buy
42,634
+32,055
+303% +$126K ﹤0.01% 4118
2024
Q4 		$45.4K Hold
10,579
– – ﹤0.01% 4221
2024
Q3 		$27.6K Hold
10,579
– – ﹤0.01% 4279
2024
Q2 		$23.5K Hold
10,579
– – ﹤0.01% 4350
2024
Q1 		$51.1K Hold
10,579
– – ﹤0.01% 4317
2023
Q4 		$132K Sell
10,579
-14,022
-57% -$120K ﹤0.01% 4273
2023
Q3 		$118K Sell
24,601
-3,963
-14% -$29.9K ﹤0.01% 4328
2023
Q2 		$364K Sell
28,564
-203
-0.7% -$1.99K ﹤0.01% 4198
2023
Q1 		$245K Sell
28,767
-507
-2% -$11.1K ﹤0.01% 4291
2022
Q4 		$294K Buy
29,274
+19
+0.1% +$278 ﹤0.01% 4227
2022
Q3 		$475K Buy
29,255
+1,453
+5% +$44.3K ﹤0.01% 4227
2022
Q2 		$897K Hold
27,802
– – ﹤0.01% 4124
2022
Q1 		$1.86M Buy
27,802
+1,272
+5% +$83.2K ﹤0.01% 3989
2021
Q4 		$1.49M Buy
26,530
+1,840
+7% +$148K ﹤0.01% 4140
2021
Q3 		$2.49M Buy
24,690
+9,334
+61% +$981K ﹤0.01% 3991
2021
Q2 		$1.9M Buy
+15,356
New +$2.5M ﹤0.01% 3975

Other funds holding VVOS

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AWA
Acorn Wealth Advisors Grand Blanc, Michigan $343M AUM 15.24% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Vanguard Group's VVOS Position: Q4 2025 in Review

Vanguard Group increased its Vivos Therapeutics (VVOS) stake by 233% in Q4 2025, buying an estimated $527K and bringing the position to 304,161 shares worth $617K. The position accounts for ﹤0.01% of the portfolio, ranked #3898.

Vanguard Group first reported a position in VVOS in Q2 2021 and has held it in 19 quarters since. The position peaked at $2.49M in Q3 2021. 19 funds tracked by Wall St. Rank hold VVOS as of Q4 2025.

  • Vanguard Group held 304,161 shares of Vivos Therapeutics worth $617K as of Q4 2025.
  • Vanguard Group bought 212,700 Vivos Therapeutics shares in Q4 2025, an estimated $527K.
  • Vivos Therapeutics made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3898 holding.
  • Vanguard Group first reported a position in Vivos Therapeutics in Q2 2021 and has held it in 19 quarters since.
  • Vanguard Group's Vivos Therapeutics position peaked at $2.49M in Q3 2021.
  • 19 funds tracked by Wall St. Rank held Vivos Therapeutics as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.